MAQUET CARDIOPULMONARY AG

Manufacturer adverse-event records for MAQUET CARDIOPULMONARY AG come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2007–2023 · thin-book · elevated Death-code · balanced

Death-code intensity

MAQUET CARDIOPULMONARY AG carries an elevated Death-code share

Death-coded event_type rows are 202 of 4,249 (4.75% · elevated tercile among 443 manufacturers). Absolute volume is thin-book.

What the Death-code reading shows for MAQUET CARDIOPULMONARY AG

The standout signal for MAQUET CARDIOPULMONARY AG is Death-code intensity: 4.75% of 4,249 reports (elevated tercile), while absolute volume is thin-book.

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 2,971 (69.9% of event_type total). Peak single-year volume reaches 1,326 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,249
Total Reports
202
Event-type Death
1,044
Injury Reports
20
Device Types

Event Types

Malfunction 2,971 (69.9%)
Injury 1,044 (24.6%)
Death 202 (4.8%)
25 (0.6%)
Other 7 (0.2%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,996 (69.4%)
Required Intervention 807 (18.7%)
Other 242 (5.6%)
Death 177 (4.1%)
R 57 (1.3%)
Life Threatening 21 (0.5%)
Disability 6 (0.1%)
O 4 (0.1%)
S 3 (0.1%)
D 1 (0.0%)

Yearly Trend

07
2007: 2
08
2008: 5
09
2009: 10
10
2010: 12
11
2011: 11
12
2012: 58
13
2013: 211
14
2014: 1,101
15
2015: 1,326
16
2016: 709
17
2017: 407
18
2018: 331
19
2019: 60
21
2021: 2
22
2022: 3
23
2023: 1